Open Accessibility Menu
Hide

Structured Didactic Curriculum & Weekly Lecture Series (15%)

The didactic training is structured as modules, each consisting of a two-hour reading period and a one-on-one didactic session led by an expert in the topic. A concise reading syllabus will be provided, which will include contemporary literature (review articles and seminal original research articles), as well as Earle A. Chiles Research Institute clinical trial protocols in immuno-oncology.

For the one-on-one didactic sessions, fellows will receive interactive but formalized lectures on the topic and will also discuss the key points highlighted by the reading materials. This curriculum is designed to allow the fellow to ask questions in real-time pertaining to the subject at hand in a stress-free setting, allowing for an accelerated and customized learning experience.

The curriculum consists of 9 major units.

Unit 1: Basic tumor immunology

Unit 2: Categories of immunotherapy

Unit 3: Immune monitoring approaches

Unit 4: From bench to bedside: translational approaches

Unit 5: Clinical immunotherapeutics

Unit 6: Immunotherapy clinical trials design

Unit 7: Clinical trials monitoring and conduct

Unit 8: Tumor-specific immunologic considerations

Unit 9: Practicalities of immuno-oncology research

Practicums: Clinical/Laboratory Rotations and Observerships (15%)

Practicums will be curated by the assigned faculty advisor for each of the units. Examples of practicums for each of the units are listed below.

Unit 1: Basic tumor immunology

  • Laboratory observership in murine efficacy studies
  • OHSU immunology journal club
  • SITC Annual Meeting

Unit 2: Categories of immunotherapy

  • Radiation oncology observership
  • Longitudinal observation of patients enrolled on immunotherapy clinical trials
  • Antibody and cytokine-based immunotherapy

Unit 3: Immune monitoring approaches

  • Observership in flow cytometry immune monitoring lab: bedside back to bench
  • Pathology specimen processing observership
  • Tour of RNA/DNA sequencing facilities and faculty
  • Introduction to T-cell repertoire sequencing (looking at data analysis)

Unit 4: From bench to bedside: translational approaches

  • Observership in tumor collection/processing/cell line production
  • Animal vivarium tour

Unit 5: Clinical immunotherapeutics

  • Inpatient adoptive cellular therapy and IL-2 rotation
  • Inpatient solid tumor service rotation

Unit 6: Immunotherapy clinical trials design

  • Longitudinal observation of patients enrolled on immunotherapy clinical trials
  • Attendance to AACR/ASCO Clinical Trials Workshop in Colorado

Unit 7: Clinical trials monitoring and conduct

  • Research study nurse/RSA observership
  • IRB meeting observership

Unit 8: Tumor-specific immunologic considerations

  • Tumor board attendance

Unit 9: Practicalities of immuno-oncology research

  • OHSU Endnote software course curriculum
  • GraphPad Prism Instruction
  • NIH grant-writing workshop

Mentored Research Projects (70%)

The following are examples of research projects available for I-O fellows.

Domain 1: Clinical Trials Development

Target dates:

September – Formalize a clinical trial concept

December – Draft of clinical trial finalized

March – Apply to the AACR trials workshop

July – Attend the AACR trials workshop

Fellows will be assisted by their mentor in identifying a clinical trial concept, developing the concept with collaborators (biostatisticians, patient advocate panel, translational scientists), and writing the clinical protocol to completion. With this concept, they are urged to mount an application to the AACR/ASCO Methods in Clinical Research Workshop in Colorado, due mid-March. If successful, they will attend the week-long workup at the conclusion of their fellowship in July, and will be sponsored for travel by the fellowship program.

Because clinical trials require several years to complete, fellows should not expect to see their trial to completion during the fellowship period, but will be acknowledged as a co-author when the trial has concluded, and are urged to submit the clinical trial as a “Trials in Progress” abstract/poster at an international meeting such as the ASCO Annual Meeting or the SITC Annual Meeting.

Domain 2: Translational Biomarkers Development

Target dates:

September – Formulate a hypothesis and identify specimens

December – Conduct assay

March – Complete analysis

June – Submit for publication of abstract presentation

Fellows will be assisted in identifying biospecimens from a clinical trial or an IRB-approved retrospective specimen collection, and choosing a rationally-selected immune-based biomarker for analysis of these biospecimens. The goal is to use a translational approach (i.e. multispectral immunofluorescence or RNA transcriptional analysis) to describe the effect of immunotherapy in a cohort of patients, or to evaluate potential predictive/prognostic biomarkers in the setting of a particular disease setting.

The fellow will collaborate with expert scientists in the chosen biomarker, biostatisticians, as well as expert clinicians in the tumor type of interest. The fellow will be urged to submit the results for abstract presentation or publication.

Domain 3: Literature Review

Target dates:

September – Select a topic and identify target population

December – Collect and read all relevant literature

March – Solicit draft review to faculty for revisions

May – Submit review for final publication

To develop expertise in an immuno-oncologic sub-specialty and to demonstrate proficiency in manuscript writing, the fellow will be urged to write a literature review on an immuno-oncology topic for publication in a peer-reviewed journal. The fellow will be advised on appropriate topics and target publications, but ultimately will choose a topic of interest to them. Examples of topics include “microbiome assessment as a potential predictive biomarker in immune checkpoint blockade” or “emerging immunotherapy strategies for the treatment of hormone receptor positive breast cancer.